Objectives To evaluate the safety, tolerability, pharmacokinetics (PK), biomarker response and efficacy of E6742 in a phase I/II study in patients with systemic lupus erythematosus (SLE). Methods Two ...
Customer stories Events & webinars Ebooks & reports Business insights GitHub Skills ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果